Shenzhen YHLO Biotech Co., Ltd. (688575.SS)
CNY 16.47
(0.37%)
CNY 16.47
(0.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.03 Billion | 3.98 Billion | 1.17 Billion | 999 Million | 877.35 Million | 728.64 Million |
| Cost of Revenue | 1.05 Billion | 1.83 Billion | 508.33 Million | 397.95 Million | 432.67 Million | 440.19 Million |
| Gross Profit | 989.55 Million | 2.14 Billion | 669.56 Million | 601.05 Million | 444.68 Million | 288.45 Million |
| Operating Expenses | 825.74 Million | 874.83 Million | 417.56 Million | 323.52 Million | 291.61 Million | 224.7 Million |
| Selling, General and Administrative Expenses | 433.48 Million | 540.55 Million | 247.31 Million | 199.78 Million | 176.04 Million | 142.74 Million |
| Research and Development Expenses | 317.18 Million | 240.31 Million | 130.74 Million | 103.17 Million | 81.5 Million | 53.21 Million |
| Other Expenses | -48.71 Million | 93.97 Million | 39.5 Million | 20.55 Million | 34.06 Million | -446.09 Thousand |
| Cost and Expenses | 1.71 Billion | 2.7 Billion | 925.89 Million | 721.47 Million | 724.28 Million | 664.9 Million |
| Operating Income | 340.54 Million | 1.2 Billion | 226.83 Million | 246.56 Million | 126.01 Million | 50.13 Million |
| Interest Expense | 6.25 Million | 8.4 Million | 11.22 Million | 13.17 Million | 17.56 Million | 4.88 Million |
| Income Tax Expense | 54.9 Million | 164.97 Million | 23.9 Million | 33.54 Million | 19.89 Million | 11.65 Million |
| Earnings before Tax | 334.1 Million | 1.18 Billion | 227.75 Million | 241.5 Million | 125.97 Million | 49.68 Million |
| Net Income | 355.01 Million | 1.01 Billion | 204.74 Million | 210.53 Million | 107.54 Million | 38.03 Million |
| Earnings Per Share Basic | 0.62 | 1.79 | 0.36 | 0.37 | 0.19 | 0.08 |
| Earnings Per Share Diluted | 0.62 | 1.78 | 0.36 | 0.37 | 0.19 | 0.08 |
| Weighted Average Shares Outstanding | 568.12 Million | 565.58 Million | 567 Million | 567 Million | 567 Million | 483.88 Million |
| Weighted Average Shares Outstanding (Diluted) | 572.6 Million | 568.75 Million | 567 Million | 567 Million | 567 Million | 484.06 Million |
| Gross Margin | 0.49 | 0.54 | 0.57 | 0.60 | 0.51 | 0.40 |
| EBIT Margin | 0.26 | 0.36 | 0.30 | 0.34 | 0.23 | 0.12 |
| Profit Margin | 0.17 | 0.25 | 0.17 | 0.21 | 0.12 | 0.05 |
| EBITDA | 537.36 Million | 1.33 Billion | 344.74 Million | 324.17 Million | 183.12 Million | 76.03 Million |
| Earnings Before Tax Margin | 0.17 | 0.30 | 0.19 | 0.25 | 0.14 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 433.82 Million | 523.86 Million | 429.66 Million | 504.41 Million | 2.03 Billion | 469.96 Million |
| Cost of Revenue | 143.84 Million | 248.59 Million | 162.43 Million | 211.53 Million | 1.05 Billion | 175.76 Million |
| Gross Profit | 289.97 Million | 275.26 Million | 267.23 Million | 292.87 Million | 989.55 Million | 294.2 Million |
| Operating Expenses | 225.52 Million | 163.77 Million | 210.09 Million | 260.65 Million | 778.06 Million | 222.59 Million |
| Selling, General and Administrative Expenses | 356.14 Million | 103.8 Million | 133.57 Million | 125.78 Million | - | 206.05 Million |
| Research and Development Expenses | 75.21 Million | 63.19 Million | 83.8 Million | 97.01 Million | - | 76.78 Million |
| Other Expenses | -205.84 Million | 3.22 Million | 7.28 Million | -37.85 Million | -48.71 Million | -3.36 Million |
| Cost and Expenses | 369.37 Million | 412.37 Million | 372.52 Million | 472.19 Million | 1.82 Billion | 398.36 Million |
| Operating Income | 43.46 Million | 111.48 Million | 57.13 Million | 32.22 Million | 211.48 Million | 136.68 Million |
| Interest Expense | 5.66 Million | 1.54 Million | 1.14 Million | 2.98 Million | 6.25 Million | 363.41 Thousand |
| Income Tax Expense | 9.04 Million | 10.78 Million | 7.55 Million | 19.05 Million | 54.9 Million | 3.85 Million |
| Earnings before Tax | 46.43 Million | 116.94 Million | 71.61 Million | 69.84 Million | 349.56 Million | 132.64 Million |
| Net Income | 45.6 Million | 106.99 Million | 66.03 Million | 69.99 Million | 355.01 Million | 143.48 Million |
| Earnings Per Share Basic | 0.08 | 0.19 | 0.12 | 0.12 | - | 0.25 |
| Earnings Per Share Diluted | 0.08 | 0.19 | 0.12 | 0.12 | - | 0.25 |
| Weighted Average Shares Outstanding | 569.27 Million | 569.27 Million | 568.3 Million | 568.12 Million | 568.12 Million | 568.12 Million |
| Weighted Average Shares Outstanding (Diluted) | 569.27 Million | 569.27 Million | 568.3 Million | 591.57 Million | 572.6 Million | 568.12 Million |
| Gross Margin | 0.67 | 0.53 | 0.62 | 0.58 | 0.49 | 0.63 |
| EBIT Margin | 0.12 | 0.33 | 0.16 | 0.18 | - | 0.38 |
| Profit Margin | 0.11 | 0.20 | 0.15 | 0.14 | 0.17 | 0.31 |
| EBITDA | 52.09 Million | 171.33 Million | 68.73 Million | 89.07 Million | - | 179.21 Million |
| Earnings Before Tax Margin | 0.10 | 0.21 | 0.13 | 0.06 | 0.10 | 0.29 |
CECO
5Y7
000755
Q
CHRW
FMC